We are live on ! Find out more

2,903 hedge funds and large institutions have $142B invested in Merck in 2021 Q4 according to their latest regulatory filings, with 387 funds opening new positions, 1,257 increasing their positions, 960 reducing their positions, and 92 closing their positions.

New
Increased
Maintained
Reduced
Closed

321% more first-time investments, than exits

New positions opened: 387 | Existing positions closed: 92

58% more call options, than puts

Call options by funds: $3.26B | Put options by funds: $2.06B

31% more repeat investments, than reductions

Existing positions increased: 1,257 | Existing positions reduced: 960

10% more funds holding

Funds holding: 2,6482,903 (+255)

2% more capital invested

Capital invested by funds: $139B → $142B (+$3.32B)

0.53% more ownership

Funds ownership: 72.93%73.46% (+0.53%)

26% less funds holding in top 10

Funds holding in top 10: 8462 (-22)

Holders
2,903
Holders Change
+255
Holders Change %
+9.63%
% of All Funds
44.67%
Holding in Top 10
62
Holding in Top 10 Change
-22
Holding in Top 10 Change %
-26.19%
% of All Funds
0.95%
New
387
Increased
1,257
Reduced
960
Closed
92
Calls
$3.26B
Puts
$2.06B
Net Calls
+$1.2B
Net Calls Change
-$14.5M
Name Holding Trade Value Shares
Change
Change in
Stake
Creative Planning
276
Creative Planning
Kansas
$35.1M -$1.72M -21,551 -4%
DILIC
277
Dai-ichi Life Insurance Company
Japan
$35M -$7.25M -91,077 -17%
CAPTRUST Financial Advisors
278
CAPTRUST Financial Advisors
North Carolina
$35M +$12.2M +152,635 +51%
CIP
279
Cornerstone Investment Partners
Georgia
$34.9M -$11.8M -148,214 -25%
ERSOT
280
Employees Retirement System of Texas
Texas
$34.7M
RA
281
Rovida Advisors
Florida
$34.6M
BCIM
282
British Columbia Investment Management
British Columbia, Canada
$34.1M -$1.85M -23,182 -5%
BAMF
283
BI Asset Management Fondsmaeglerselskab
Denmark
$33.9M +$859K +10,791 +3%
Cambridge Investment Research Advisors
284
Cambridge Investment Research Advisors
Iowa
$33.7M +$864K +10,846 +3%
DRZID
285
DePrince Race & Zollo Inc (DRZ)
Florida
$33.7M +$3.23M +40,577 +10%
PI
286
PineBridge Investments
New York
$33.4M +$26.6M +333,707 +327%
LWCFA
287
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$33.4M +$621K +7,799 +2%
GIBU
288
Gulf International Bank (UK)
United Kingdom
$33M -$5.81M -73,007 -14%
SF
289
Synovus Financial
Georgia
$33M +$2.83M +35,513 +9%
FT
290
Fiduciary Trust
Massachusetts
$33M -$130K -1,629 -0.4%
PAM
291
Panagora Asset Management
Massachusetts
$32.9M +$13.1M +164,536 +62%
ST
292
Sabal Trust
Florida
$32.8M +$1.22M +15,326 +4%
GG
293
Gofen & Glossberg
Illinois
$32.6M +$226K +2,842 +0.7%
WB
294
WesBanco Bank
West Virginia
$32.5M -$181K -2,272 -0.5%
Public Sector Pension Investment Board (PSP Investments)
295
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$32.3M -$435K -5,460 -1%
IG
296
ING Group
Netherlands
$32.1M -$1.8M -22,571 -5%
BCIM
297
Black Creek Investment Management
Ontario, Canada
$31.9M -$239K -3,000 -0.7%
Loomis, Sayles & Company
298
Loomis, Sayles & Company
Massachusetts
$31.6M -$13.9M -174,861 -30%
WT
299
Whittier Trust
California
$31.6M +$581K +7,293 +2%
SAI
300
Systematic Alpha Investments
New Jersey
$31.5M

MRK Hedge Fund Activity: Q4 2021 in Review

2,903 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q4 2021, worth a combined $142B — up 2.4% from $139B a quarter earlier.

Buyers outnumbered sellers: 387 funds opened new MRK positions and 92 closed out — a net gain of 295 holders — while 1,257 added to existing stakes and 960 trimmed.

The largest buyer was BlackRock, adding an estimated $823M. The largest seller was Capital International Investors, cutting an estimated $481M.

  • 2,903 institutional investors held Merck (MRK) as of Q4 2021, up from 2,648 in Q3 2021.
  • Funds reported $142B of Merck stock for Q4 2021, up 2.4% quarter-over-quarter.
  • 387 funds opened new Merck positions in Q4 2021 and 92 closed out, a net change of +295 holders.
  • The largest Merck buyer in Q4 2021 was BlackRock, an estimated $823M added.
  • The largest Merck seller in Q4 2021 was Capital International Investors, an estimated $481M sold.

Based on aggregated 13F filings for Q4 2021.